202 related articles for article (PubMed ID: 30376562)
21. Chemical-genomic profiling: systematic analysis of the cellular targets of bioactive molecules.
Andrusiak K; Piotrowski JS; Boone C
Bioorg Med Chem; 2012 Mar; 20(6):1952-60. PubMed ID: 22261022
[TBL] [Abstract][Full Text] [Related]
22. iSeq: A New Double-Barcode Method for Detecting Dynamic Genetic Interactions in Yeast.
Jaffe M; Sherlock G; Levy SF
G3 (Bethesda); 2017 Jan; 7(1):143-153. PubMed ID: 27821633
[TBL] [Abstract][Full Text] [Related]
23. A high-content, cell-based screen identifies micropolyin, a new inhibitor of microtubule dynamics.
De Rycker M; Rigoreau L; Dowding S; Parker PJ
Chem Biol Drug Des; 2009 Jun; 73(6):599-610. PubMed ID: 19635051
[TBL] [Abstract][Full Text] [Related]
24. QSAR Modeling of the Arylthioindole Class of Colchicine Polymerization Inhibitors as Anticancer Agents.
Habibpour E; Ahmadi S
Curr Comput Aided Drug Des; 2017; 13(2):143-159. PubMed ID: 28120704
[TBL] [Abstract][Full Text] [Related]
25. Discovery of small molecule inhibitors that interact with γ-tubulin.
Friesen DE; Barakat KH; Semenchenko V; Perez-Pineiro R; Fenske BW; Mane J; Wishart DS; Tuszynski JA
Chem Biol Drug Des; 2012 May; 79(5):639-52. PubMed ID: 22268380
[TBL] [Abstract][Full Text] [Related]
26. Structures of a diverse set of colchicine binding site inhibitors in complex with tubulin provide a rationale for drug discovery.
Wang Y; Zhang H; Gigant B; Yu Y; Wu Y; Chen X; Lai Q; Yang Z; Chen Q; Yang J
FEBS J; 2016 Jan; 283(1):102-11. PubMed ID: 26462166
[TBL] [Abstract][Full Text] [Related]
27. τ-SGA: synthetic genetic array analysis for systematically screening and quantifying trigenic interactions in yeast.
Kuzmin E; Rahman M; VanderSluis B; Costanzo M; Myers CL; Andrews BJ; Boone C
Nat Protoc; 2021 Feb; 16(2):1219-1250. PubMed ID: 33462440
[TBL] [Abstract][Full Text] [Related]
28. A data integration approach for cell cycle analysis oriented to model simulation in systems biology.
Alfieri R; Merelli I; Mosca E; Milanesi L
BMC Syst Biol; 2007 Aug; 1():35. PubMed ID: 17678529
[TBL] [Abstract][Full Text] [Related]
29. Design, synthesis and biological evaluation of novel macrocyclic bisbibenzyl analogues as tubulin polymerization inhibitors.
Sun B; Li L; Hu QW; Xie F; Zheng HB; Niu HM; Yuan HQ; Lou HX
Eur J Med Chem; 2016 Oct; 121():484-499. PubMed ID: 27318123
[TBL] [Abstract][Full Text] [Related]
30. Mosaic gene network modelling identified new regulatory mechanisms in HCV infection.
Popik OV; Petrovskiy ED; Mishchenko EL; Lavrik IN; Ivanisenko VA
Virus Res; 2016 Jun; 218():71-8. PubMed ID: 26481968
[TBL] [Abstract][Full Text] [Related]
31. Synthetic genetic array analysis for global mapping of genetic networks in yeast.
Kuzmin E; Sharifpoor S; Baryshnikova A; Costanzo M; Myers CL; Andrews BJ; Boone C
Methods Mol Biol; 2014; 1205():143-68. PubMed ID: 25213244
[TBL] [Abstract][Full Text] [Related]
32. Network and pathway analysis of compound-protein interactions.
Brennan RJ; Nikolskya T; Bureeva S
Methods Mol Biol; 2009; 575():225-47. PubMed ID: 19727618
[TBL] [Abstract][Full Text] [Related]
33. Gene expression complex networks: synthesis, identification, and analysis.
Lopes FM; Cesar RM; Costa Lda F
J Comput Biol; 2011 Oct; 18(10):1353-67. PubMed ID: 21548810
[TBL] [Abstract][Full Text] [Related]
34. Tubulin inhibitor identification by bioactive conformation alignment pharmacophore-guided virtual screening.
Nagarajan S; Choi MJ; Cho YS; Min SJ; Keum G; Kim SJ; Lee CS; Pae AN
Chem Biol Drug Des; 2015 Nov; 86(5):998-1016. PubMed ID: 25845798
[TBL] [Abstract][Full Text] [Related]
35. Network based elucidation of drug response: from modulators to targets.
Iorio F; Saez-Rodriguez J; di Bernardo D
BMC Syst Biol; 2013 Dec; 7():139. PubMed ID: 24330611
[TBL] [Abstract][Full Text] [Related]
36. SANTA: quantifying the functional content of molecular networks.
Cornish AJ; Markowetz F
PLoS Comput Biol; 2014 Sep; 10(9):e1003808. PubMed ID: 25210953
[TBL] [Abstract][Full Text] [Related]
37. The Mechanism of the Interactions of Pironetin Analog/Combretastatin A-4 Hybrids with Tubulin.
Torijano-Gutiérrez S; Vilanova C; Díaz-Oltra S; Murga J; Falomir E; Carda M; Redondo-Horcajo M; Díaz JF; Barasoain I; Marco JA
Arch Pharm (Weinheim); 2015 Aug; 348(8):541-7. PubMed ID: 26085125
[TBL] [Abstract][Full Text] [Related]
38. Why are membrane targets discovered by phenotypic screens and genome sequencing in Mycobacterium tuberculosis?
Goldman RC
Tuberculosis (Edinb); 2013 Nov; 93(6):569-88. PubMed ID: 24119636
[TBL] [Abstract][Full Text] [Related]
39. Application of GA-MLR for QSAR Modeling of the Arylthioindole Class of Tubulin Polymerization Inhibitors as Anticancer Agents.
Ahmadi S; Habibpour E
Anticancer Agents Med Chem; 2017; 17(4):552-565. PubMed ID: 27528182
[TBL] [Abstract][Full Text] [Related]
40. Identification of functional modules using network topology and high-throughput data.
Ulitsky I; Shamir R
BMC Syst Biol; 2007 Jan; 1():8. PubMed ID: 17408515
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
